Evidence for Age and Sex Differences in the Secondary Prevention of Stroke in Scottish Primary Care
- 1 August 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (8) , 1771-1775
- https://doi.org/10.1161/01.str.0000173398.99163.9e
Abstract
Background and Purpose— Secondary preventive measures play an important role in the reduction of stroke, the third largest cause of death in Scotland. We investigated whether sex, age, or deprivation differences existed in the secondary prevention of stroke in primary care. Methods– A retrospective cross-sectional study using a computerized database with 61 practices (377 439 patients) to identify group differences in secondary preventive therapy between March 2003 and April 2004 for 10 076 patients with a diagnosis of any stroke. Results— Women with any stroke were more likely than men to be prescribed a thiazide (odds ratios [OR], 1.60; 95% confidence interval [CI], 1.46 to 1.75) but less likely to be prescribed an angiotensin-converting enzyme inhibitor (OR, 0.73; 95% CI, 0.67 to 0.81). Women with ischemic stroke were less likely to receive either an antiplatelet or warfarin (OR, 0.84; 95% CI, 0.75 to 0.94) or statin therapy (OR, 0.82; 95% CI, 0.74 to 0.90) than men. Women with atrial fibrillation rece...Keywords
This publication has 15 references indexed in Scilit:
- Evidence for inequalities in the management of coronary heart disease in ScotlandHeart, 2005
- Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II studyBritish Journal of Clinical Pharmacology, 2004
- Sex Differences in Management and Outcome After StrokeStroke, 2003
- Sex Differences in the Clinical Presentation, Resource Use, and 3-Month Outcome of Acute Stroke in EuropeStroke, 2003
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialThe Lancet, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attackThe Lancet, 2001
- Blood pressure and risk of stroke in patients with cerebrovascular diseaseBMJ, 1996
- Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial FibrillationArchives of internal medicine (1960), 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994